Phenolic and Flavonoid Contents and Antioxidant Capacity of Annona muricata Leaf Extracts and Effects of a Selected Extract on Metabolic Biomarkers and Tissue-Specific Lipid Metabolism in Diet-Induced Obese Mice

Vol.2, 2025 - 348310
In-person poster presentation
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Altered lipid metabolism contributes to obesity-associated metabolic dysfunction and hepatic steatosis. Annona muricata leaves are a promising source of bioactive compounds; however, they remain an underutilized plant by-product, and evidence linking their bioactive potential to metabolic and molecular effects in obesity remains limited. This study aimed to compare the phenolic and flavonoid contents and antioxidant capacity of six A. muricata leaf extracts obtained under different extraction conditions, select the most promising extract based on these characteristics, and evaluate its effects on metabolic biomarkers and tissue-specific lipid metabolism in diet-induced obese mice.

Six A. muricata leaf extracts were obtained by maceration, ultrasound-assisted extraction, or water-bath extraction using different ethanol concentrations. Total phenolic and flavonoid contents were determined by spectrophotometric methods, and antioxidant capacity was assessed using DPPH, ABTS, and FRAP assays. The selected extract was subsequently evaluated in male BALB/c mice (n=42) assigned to  six groups: normal diet, high-fat diet (HFD), HFD plus extract (250 or 500 mg/kg), HFD plus metformin, or a transition group. After 8 weeks of HFD-induced obesity, treatments were administered for 6 weeks. Metabolic biomarkers and hepatic steatosis were evaluated, and the expression of lipid metabolism-related genes in liver and adipose tissue was assessed by RT-qPCR.

Among the six extracts, the 96% ethanolic ultrasound-assisted extract showed high total phenolic content (126.39 ± 7.28 mg GAE/g), and the higher flavonoid content (78.19 ± 1.34 mg QE/g) and FRAP capacity (2616.38 ± 39.44 µmol TE/g) than all other extracts (p<0.05) and was selected for in vivo evaluation. Compared with untreated HFD mice, the selected extract at 500 mg/kg reduced serum glucose, triglycerides, ALT, and AST and increased HDL-cholesterol (all p<0.05). Hepatic steatosis decreased from 21.1 ± 3.1% to 6.3 ± 2.3%. In the liver, treatment increased Ampk and Pparα and decreased Pparγ, Srebf1, and Fasn expression; in adipose tissue, it increased Ampk and decreased Pparγ, C/ebpα, and Fabp4 expression (all p<0.05).

These findings indicate that the selected extract combined favorable bioactive profile with metabolic and hepatic improvements and tissue-specific modulation of lipid metabolism-related genes. Overall, the results support A. muricata leaves as an underutilized source of bioactive compounds with potential for further investigation in obesity-associated metabolic dysfunction.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Instituições
  • 1 Universidad Nacional Agraria La Molina
  • 2 Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago,
  • 3 Department of Nutrition, Universidad Nacional Agraria La Molina, Lima, Peru.
Eixo Temático
  • Food and Health - (FH)
Palavras-chave
Annona muricata
phenolic compounds
antioxidant capacity
obesity
lipid metabolism.